Financial Security Advisor’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$255K Buy
2,016
+12
+0.6% +$1.58K 0.04% 141
2026
Q1
$279K Sell
2,004
-29
-1% -$4.06K 0.05% 130
2025
Q4
$250K Buy
2,033
+12
+0.6% +$1.46K 0.05% 135
2025
Q3
$224K Buy
2,021
+44
+2% +$5K 0.05% 131
2025
Q2
$219K Buy
1,977
+11
+0.6% +$1.17K 0.05% 120
2025
Q1
$220K Buy
+1,966
New +$203K 0.06% 114

Other funds holding GILD

Financial Security Advisor's GILD Position: Q2 2026 in Review

Financial Security Advisor increased its Gilead Sciences (GILD) stake by 0.6% in Q2 2026, buying an estimated $1.58K and bringing the position to 2,016 shares worth $255K. The position accounts for 0.04% of the portfolio, ranked #141.

Financial Security Advisor first reported a position in GILD in Q1 2025 and has held it in 6 quarters since. The position peaked at $279K in Q1 2026. 2,274 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Financial Security Advisor held 2,016 shares of Gilead Sciences worth $255K as of Q2 2026.
  • Financial Security Advisor bought 12 Gilead Sciences shares in Q2 2026, an estimated $1.58K.
  • Gilead Sciences made up 0.04% of Financial Security Advisor's portfolio in Q2 2026, its #141 holding.
  • Financial Security Advisor first reported a position in Gilead Sciences in Q1 2025 and has held it in 6 quarters since.
  • Financial Security Advisor's Gilead Sciences position peaked at $279K in Q1 2026.
  • 2,274 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Financial Security Advisor's 13F filing for Q2 2026, filed 11 Aug 2026.